Even the CEO appears puzzled by the stocks behavior.Immucor's president and chief executive officer, Edward L. Gallup, commenting on the volume of trading in the Company's stock, stated, "The Company recently provided guidance for the current quarter and fiscal year in a press release and conference call on January 7, 2003. We have not altered that guidance and are not aware of the reasons for the recent volume of trading in our stock."taken from a BLUD press releaseDerek
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Rat